Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - TOTAL OTHER INCOME
Total Other Income CRVS - Corvus Pharmaceuticals, Inc.
-3.62 M
LAST VALUE
11.37%
2 YEAR CAGR
-20.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR